Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Aug 19 · below the Ichimoku cloud · RSI 20 (oversold) · MACD below its signal · 2% above its 52-week low
None of the 29 investors followed here reported a position in IVF in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a IVF trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 81.9 | -30.7 | -42.7 | -30.9 | 0.0 | 1.1 | -50.7 | 9.9 | -11.7 | -29.7 | −83.0% | ||
| 2025 | -43.1 | -19.7 | -55.0 | 19.5 | -29.3 | -47.9 | -31.1 | -47.3 | -20.8 | -28.8 | -48.1 | -66.5 | −99.7% |
| 2024 | -25.9 | 15.0 | -1.7 | -11.5 | -14.0 | -2.3 | 7.1 | -11.0 | -11.4 | 5.4 | 30.9 | -17.3 | −40.0% |
| 2023 | 65.1 | -15.7 | 8.3 | -43.7 | -29.2 | -21.6 | 24.0 | -69.6 | -47.7 | 58.2 | 49.6 | -27.8 | −84.1% |
| 2022 | -4.5 | -5.3 | -12.3 | -42.8 | -35.1 | -34.7 | 54.7 | -2.2 | 9.5 | 8.5 | -14.9 | -56.7 | −87.3% |
| 2021 | -1.7 | 7.4 | 36.2 | -5.1 | 6.6 | 6.2 | -8.4 | -9.6 | -15.3 | 5.8 | -10.7 | 8.1 | +10.6% |
| 2020 | -7.1 | −7.1% |
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Dec 2, 2025 | Szot Matthew KDirector | Sale at price 1.52 per share. | 4 | $6 |
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.